Data as of Mar 07
| -0.13 / -0.22%|
The 15 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 56.00, with a high estimate of 67.00 and a low estimate of 44.00. The median estimate represents a -4.42% decrease from the last price of 58.59.
The current consensus among 19 polled investment analysts is to Hold stock in Eli Lilly and Co. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.